Fredrik Hellem Schjesvold, MD, PhD

• Multiple Myeloma

Fredrik Schjesvold, MD, PhD, is the founder and leader of Oslo Myeloma Center at Oslo University Hospital. He earned his medical degree from the University of Oslo in 2001 and did his hematological training at the Department of Hematology at Oslo University Hospital. He has previously headed the units of hematology at Diakonhjemmet hospital and Bærum hospital in Norway. 

Dr. Schjesvold is an international expert on Multiple Myeloma, with one of Europe’s largest centers for clinical research in this disease. This includes being the national coordinator of 30 clinical myeloma trials, and in addition being the principal investigator of 3 large myeloma studies. He is also an expert on light chain amyloidosis.

Dr. Schjesvold is on the steering committee of the Nordic Myeloma Study Group, where he leads the clinical trial task force. He leads the Norwegian Myeloma Group and is the main author of the Norwegian Myeloma Guidelines. He is also a member of the International Myeloma Working Group, the International Myeloma Society, the European Hematology Association, and the American Society of Hematology.